Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 46

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 46
---
. Dec received a grant of 12,000 RSUs, each of Dr. Rubin, Dr. Bhatt and Mr. Mottola received grants of 5,000 RSUs. Other benefits Our executive officers are eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life insurance, disability insurance, Employee Stock Purchase Plan (“ESPP”) and our 401(k) plan, in each case on the same basis and subject to the same terms as our other employees. The Company makes a safe harbor match to the 401(k) Plan for all participants. There were no special benefits or perquisites provided to any executive officer in 2023. The Company does not maintain a pension program or a deferred compensation plan for executives or for any other employees, other than the Supernus Supplemental Executive Retirement Plan (SERP), which was established for the benefit of Jack Khattar for the sole purpose of receiving funds from a Shire (the former parent of the predecessor of the Company) SERP and providing a continuing deferral program under the Supernus SERP. No additional contributions have been made to the account by Supernus or by Mr. Khattar personally since the Supernus SERP was established. Corporate Policies Covering Executive Compensation Incentive Compensation Recoupment Policy Our Board adopted an Incentive Compensation Recoupment Policy that applies to all of the Company’s current and former executive officers and vice presidents and is intended to conform to the final clawback rule adopted by the SEC implementing applicable provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Nasdaq’s related proposed listing standard, in each case relating to recoupment of incentive-based compensation. Under the policy any cash bonus and/or equity compensation granted by the Company after the date of adoption is subject to recoupment. The policy provides for discretionary recoupment of compensation if (i) the Board of Directors determines that a covered executive engaged in fraud, intentional misconduct or gross negligence that requires a material restatement of financial results, and (ii) such fraud or intentional misconduct resulted in an incorrect determination that an incentive compensation performance goal had been achieved, whereupon the Board of Directors may take appropriate action to recover from such covered executive any incentive compensation resulting from such incorrect determination paid to such covered executive to the extent it was based on such incorrect determination. The policy further provides for the mandatory recoupment of compensation in the event that the Company is required to prepare an accounting restatement due to the material noncom